Literature DB >> 17632408

Granulocyte colony-stimulating factor for the induction of T-cell tolerance.

Sergio Rutella1.   

Abstract

In recent years, investigators have unraveled a previously unrecognized role for granulocyte colony-stimulating factor (G-CSF) in the regulation of T-cell and dendritic cell functions. The experimental evidence in favor of G-CSF-mediated immune regulation includes the ability to skew T-cell cytokine secretion to T-helper type 2 responses, and to promote regulatory T-cell and tolerogenic dendritic cell differentiation. Accordingly, beneficial effects of G-CSF have been detected in animal models of immune-mediated diseases, including posttransplantation graft-versus-host disease, experimental autoimmune encephalomyelitis, lupus nephritis, inflammatory bowel disease, and diabetes. The growing body of evidence supporting a novel role for G-CSF in the induction of T-cell tolerance is reviewed herein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632408     DOI: 10.1097/01.tp.0000269611.66517.bf

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

1.  IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?

Authors:  Babbette Lamarca; Justin Brewer; Kedra Wallace
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-07-01

2.  The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2010-04

3.  Intradermal alpha1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease.

Authors:  H Ma; Y Lu; H Li; M Campbell-Thompson; M Parker; C Wasserfall; M Haller; M Brantly; D Schatz; M Atkinson; S Song
Journal:  Diabetologia       Date:  2010-07-01       Impact factor: 10.122

Review 4.  The multifaceted effects of granulocyte colony-stimulating factor in immunomodulation and potential roles in intestinal immune homeostasis.

Authors:  Andrew Martins; Jiahuai Han; Sung O Kim
Journal:  IUBMB Life       Date:  2010-08       Impact factor: 3.885

5.  Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes.

Authors:  M J Haller; M A Atkinson; C H Wasserfall; T M Brusko; C E Mathews; M Hulme; M Cintron; J Shuster; K McGrail; A Posgai; D Schatz
Journal:  Clin Exp Immunol       Date:  2015-12-07       Impact factor: 4.330

6.  Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells.

Authors:  Maura Rossetti; Silvia Gregori; Maria Grazia Roncarolo
Journal:  Eur J Immunol       Date:  2010-10-19       Impact factor: 5.532

7.  Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.

Authors:  Anna-Marie Fairhurst; Chun Xie; Yuyang Fu; Andrew Wang; Christopher Boudreaux; Xin J Zhou; Ricardo Cibotti; Anthony Coyle; John E Connolly; Edward K Wakeland; Chandra Mohan
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

Review 8.  Islet-Resident Dendritic Cells and Macrophages in Type 1 Diabetes: In Search of Bigfoot's Print.

Authors:  Henner Zirpel; Bart O Roep
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-12       Impact factor: 5.555

9.  Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.

Authors:  Po-Kuan Chao; Kwok-Tung Lu; Yun-Lin Lee; Jin-Chung Chen; Hung-Li Wang; Yi-Ling Yang; Mei-Yun Cheng; Ming-Feng Liao; Long-Sun Ro
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

10.  Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.

Authors:  Matthew J Parker; Song Xue; John J Alexander; Clive H Wasserfall; Martha L Campbell-Thompson; Manuela Battaglia; Silvia Gregori; Clayton E Mathews; Sihong Song; Misty Troutt; Scott Eisenbeis; John Williams; Desmond A Schatz; Michael J Haller; Mark A Atkinson
Journal:  Diabetes       Date:  2009-07-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.